RESTASIS vs TREMFYA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. RESTASIS and TREMFYA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	RESTASIS	TREMFYA
Rating	72/100	New
Pharmacy pays	~$52.85 /30	—
Type	RX	RX
Active ingredient	CYCLOSPORINE	GUSELKUMAB
Manufacturer	Allergan	Janssen Biotech
Dosage forms	Emulsion	Injectable
Drug class	Calcineurin Inhibitor Immunosuppressant	—
Boxed warning	None	None
Half-life	about 8.4 hours (range 5 to 18 hours)	—
Treats	Rheumatoid Arthritis, Focal Segmental Glomerulosclerosis, Systemic Lupus Erythematosus	Psoriasis

restasis tremfya

Rating

72/100

New

Pharmacy pays

~$52.85 /30

—

Type

Active ingredient

CYCLOSPORINE

GUSELKUMAB

Manufacturer

Allergan

Janssen Biotech

Dosage forms

Emulsion

Injectable

Drug class

Calcineurin Inhibitor Immunosuppressant

—

Boxed warning

None

Half-life

about 8.4 hours (range 5 to 18 hours)

—

Treats

Rheumatoid Arthritis, Focal Segmental Glomerulosclerosis, Systemic Lupus Erythematosus

Psoriasis

Frequently asked questions

What is the difference between Restasis and Tremfya?

Restasis contains Cyclosporine, while Tremfya contains Guselkumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.